Fatal acute hepatic failure secondary to thrombotic portal venopathy after commencing abemaciclib and fulvestrant treatment for advanced breast carcinoma: a unique autopsy finding-Reference-Cited by-同舟云学术

Fatal acute hepatic failure secondary to thrombotic portal venopathy after commencing abemaciclib and fulvestrant treatment for advanced breast carcinoma: a unique autopsy finding

Published:2021-05-14 Issue:7 Volume:27 Page:612-614
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Haynes Harry R¹²^ORCID,Mohan Vivek³,Mozayani Behrang⁴,Gallagher Patrick⁵

Affiliation:

1. Department of Cellular Pathology Great Western Hospital Swindon UK

2. Translational Health SciencesUniversity of Bristol Bristol UK

3. Bristol Haematology and Oncology Centre University Hospitals Bristol NHS Foundation Trust Bristol UK

4. Department of Cellular Pathology North Bristol NHS Trust Bristol UK

5. Medical Education University of Bristol Bristol UK

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.14238

Reference14 articles.

1. Pathogenesis of Hepatic Encephalopathy and Brain Edema in Acute Liver Failure

2. Pathology of non-cirrhotic portal hypertension and incomplete septal cirrhosis

3. MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives

5. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute-on-Chronic Liver Failure Incited by Cyclin-Dependent Kinase Inhibitor Therapy for Breast Cancer Effectively Treated With Liver Transplantation;ACG Case Reports Journal;2024-01

2. Side effects of anti-cancer medications;Side Effects of Drugs Annual;2022

3. Abemaciclib/fulvestrant;Reactions Weekly;2021-09